- Country: Slovakia
- Summary: Dinutuximab 4.5 Mg/1 Ml, Concentrate on the Infusion Switch: the Subject of the Order is a Drug with an Arranged Dinutuximab in a Concentration of 4.5 Mg/1Ml; Concentrate on Infusion Solution, Supplement: Con Infin 4.5 Ml/20 M ...
- SKT Ref No: 123038457
- Deadline: 21 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 902994.5
- Notice Type: Tender
- Document Ref. No.: 11862 - VST
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender for Dinutuximab 4.5 mg/1 ml, concentrate on the infusion switch: The subject of the order is a drug with an arranged dinutuximab in a concentration of 4.5 mg/1ml; Concentration on infusion solution, supplement: con infin inflammation 4.5 ml/20 mg (drug. Inj. Skl). 12 months, which was filed before the introduction of chemotherapy and achieved at least a partial response, followed by myeloablative treatment and stem cell transplantation, as well as in patients with historia relay or refractive neuroblastom with or without residual disease. The treatment With this medicine, it is folded from 5 cycles of IDUCIC in a row, and every cycle lasts 35 days. The individual dose is determined according to the body area and has a total of 100 mg/m2 per cycle. Type of Candy: Goods 4.1.3 Range Obtained Valuant Value (BT-27-Procedure) (value): 902 994.5. Ramco's Agreement value of Ramco's Agreement (BT-271-Procedure) (value): 948 144.23Maximal value of Ramc's Agreement (BT-271-Procedure) (currency): EURHOGRAVA CLASSIFICATIATION CLASSIFICATION: Common dictionary of procurement CPV code: antineoplastic and immunomodulatory agentinformations on additional classification of the subject of the order of additional classification of the subject of the Classifying Classification: Common Obstazation dictionary 4.1 on the place of performance of the insinformation on the place of filling: L. Svoboda square 4 -month: Banska BystricpsΔ: 97409nizsia ground unit of the country: Banska Bystrica Katzkrajina: Slovakia4.2 Information on the procedure4.2.1 Price procedure: Public sulk sulfur. Part5.1 Information on Part5.1.1 Part: Dinutuximab 4.5 mg/1 ml, concentrate on infusy solution Dinutuximab 4.5 mg/1 ml, concentrate on infusic solution (LOT-0001)UΔelOpis The venerable ...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDinutuximab 4.5 Mg/1 Ml, Concentrate on the Infusion Switch: the Subject of the Order is a Drug with an Arranged Dinutuximab in a Concentration of 4.5 Mg/1Ml; Concentrate on Infusion Solution, Supplement: Con Infin 4.5 Ml/20 M ... - Slovakia Tender
The CHILDREN'S FACULTY HOSPITAL WITH POLYCLINIC BANSKA BYSTRICA, a Government sector organization in Slovakia, has announced a new tender for Dinutuximab 4.5 Mg/1 Ml, Concentrate on the Infusion Switch: the Subject of the Order is a Drug with an Arranged Dinutuximab in a Concentration of 4.5 Mg/1Ml; Concentrate on Infusion Solution, Supplement: Con Infin 4.5 Ml/20 M .... This tender is published on SlovakiaTenders under SKT Ref No: 123038457 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-21.
The estimated tender value is EUR 902994.5, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
